Skip to content

OGTT

OTHER19 trials

Sponsors

Ullevaal University Hospital, Rigshospitalet, Denmark, The University of Texas Medical Branch, Galveston, University Hospital, Gentofte, Copenhagen, Sheba Medical Center

Conditions

AcromegalyAdiposityAtherosclerosisBariatric Surgery CandidateCritical IllnessCystic FibrosisCystic Fibrosis-related DiabetesDiabetes

Phase 4

Unknown Phase

Type 2 Diabetes and Acute Myocardial Infarction
NCT00926133
Ullevaal University HospitalImpaired Glucose Tolerance, Inflammation, Myocardial Infarction +1
Start: 2005-11-30End: 2009-12-31Updated: 2009-06-23
Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
CompletedNCT01347801
Rigshospitalet, DenmarkHypoglycaemia
Start: 2011-03-31End: 2014-09-30Updated: 2014-09-22
Effect of Lycopene and Isoflavones on Glucose Metabolism
WithdrawnNCT01377961
The University of Texas Medical Branch, GalvestonDiabetes Mellitus, Non-Insulin-Dependent, Metabolic Syndrome
Start: 2010-09-30End: 2015-08-31Updated: 2015-06-26
Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes
CompletedNCT01492283
University Hospital, Gentofte, CopenhagenLiver Cirrhosis, Non Alcoholic Fatty Liver Disease, Type 2 Diabetes
Start: 2011-12-31End: 2014-07-31Updated: 2014-07-10
The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family
NCT01960231
Sheba Medical CenterMODY-2 Diabetes
Start: 2013-10-31End: 2017-12-31Target: 30Updated: 2017-06-20
Genetics of Fatty Liver Disease in Children
CompletedNCT01966627
Yale UniversityNon Alcoholic Fatty Liver Disease
Start: 2011-07-31End: 2017-07-31Updated: 2017-12-08
Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes
CompletedNCT02130505
Sint Franciscus GasthuisAtherosclerosis, Familial Combined Hyperlipidemia, Leukocyte Activation Disorder +1
Start: 2007-06-30End: 2008-06-30Updated: 2014-05-05
Bed Rest, Alternate Daily Fasting and Incretin Effect
CompletedNCT02134860
Rigshospitalet, DenmarkCritical Illness, Metabolic Syndrome, Type 2 Diabetes
Start: 2014-06-30End: 2014-09-30Updated: 2014-09-22
Metabolic Complications Following Knee Injury in Young and Middle Aged Patients
NCT02573662
Haugaard, Steen Bendix, M.D., DMScGlucose Metabolism Disorders, Lipid Metabolism Disorders, Sedentary Lifestyle
Start: 2015-04-30End: 2016-06-30Target: 16Updated: 2015-11-10
GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
CompletedNCT02598791
University Hospital, Gentofte, CopenhagenAdiposity, Obesity, Type 2 Diabetes
Start: 2015-10-01End: 2016-06-20Updated: 2018-12-06
Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del
WithdrawnNCT02653027
Massachusetts General HospitalCystic Fibrosis, Diabetes
Start: 2018-01-01End: 2018-05-01Updated: 2019-07-31
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
CompletedNCT02669524
University Hospital, Gentofte, CopenhagenType 2 Diabetes
Start: 2015-10-31End: 2016-08-31Updated: 2016-10-25
Cardiac (CMRI) Assessment of Acromegaly
CompletedNCT02948322
Assistance Publique - Hôpitaux de ParisAcromegaly
Start: 2014-12-31End: 2019-02-28Updated: 2019-05-15
The DNA Methylation of ARHGEF11 in Macrosomia
CompletedNCT03165643
Peking University First HospitalDiabetes, Gestational Diabetes, Macrosomia, Fetal
Start: 2014-03-06End: 2014-10-18Updated: 2017-05-24
Glucose Metabolism in Pregnant Women With a History of Bariatric Surgery, as Well as Three to Six Months After Delivery.
CompletedNCT03190148
Medical University of ViennaBariatric Surgery Candidate, Glucose Metabolism Disorders, Pregnancy Complications +1
Start: 2014-02-13End: 2016-05-01Updated: 2017-06-16
Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.
NCT05377502
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Cystic Fibrosis, Cystic Fibrosis-related Diabetes
Start: 2021-12-15End: 2022-12-31Target: 20Updated: 2022-05-17
Subjects With T2D or at Risk of T2D Cohort Follow-up
Active, not recruitingNCT05567692
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du DiabèteDiabetes Mellitus, Type 2
Start: 2023-02-10End: 2032-10-01Target: 837Updated: 2025-02-18
Bed Rest Study SBI 2023
CompletedNCT06141291
Science and Research Centre KoperHealthy Aging, Physical Inactivity
Start: 2023-08-21End: 2023-10-22Updated: 2023-11-21

Related Papers